Watch the second video in our 2025 Year in Review series. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman, looks ahead to 2026. In this video, Hardman considers potential FDA approvals, Phase 3 readouts, alternative pathways to access, and more…
This recording is exclusively for our Pα+ subscribers.
Sign-in or join Pα+ to watch this video…
Join Pα+ Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space
✓ Regular articles and deep dives across psychedelic research, policy and business
✓ Interviews with insiders
✓ Monthly interactive database and commentary on psychedelic patents
✓ Quick-take analysis of major developments
✓ A Library of primers and explainers
✓ Access to our full back catalogue
